VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+25.81%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
AUM
$241M
AUM Growth
+$50.3M
Cap. Flow
+$11.6M
Cap. Flow %
4.82%
Top 10 Hldgs %
9.37%
Holding
372
New
47
Increased
146
Reduced
160
Closed
17

Sector Composition

1 Healthcare 29.53%
2 Real Estate 18.96%
3 Energy 16.61%
4 Materials 11.31%
5 Utilities 7.08%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MRSN icon
201
Mersana Therapeutics
MRSN
$34M
$308K 0.13%
462
-157
-25% -$105K
NTLA icon
202
Intellia Therapeutics
NTLA
$1.29B
$308K 0.13%
5,662
-10,265
-64% -$558K
DTIL icon
203
Precision BioSciences
DTIL
$59.8M
$306K 0.13%
1,225
-148
-11% -$37K
TECX
204
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
$305K 0.13%
1,821
+650
+56% +$109K
CRNX icon
205
Crinetics Pharmaceuticals
CRNX
$3.35B
$303K 0.13%
21,487
+2,116
+11% +$29.8K
KRYS icon
206
Krystal Biotech
KRYS
$4.35B
$303K 0.13%
5,052
-1,794
-26% -$108K
ARWR icon
207
Arrowhead Research
ARWR
$4.02B
$302K 0.13%
3,938
-5,486
-58% -$421K
AXSM icon
208
Axsome Therapeutics
AXSM
$6.25B
$301K 0.12%
3,690
-579
-14% -$47.2K
CRSP icon
209
CRISPR Therapeutics
CRSP
$4.99B
$301K 0.12%
1,966
-3,189
-62% -$488K
FCT
210
First Trust Senior Floating Rate Income Fund II
FCT
$263M
$301K 0.12%
25,865
+489
+2% +$5.69K
DNLI icon
211
Denali Therapeutics
DNLI
$2.26B
$300K 0.12%
3,586
-8,878
-71% -$743K
TVRD
212
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
$300K 0.12%
550
-19
-3% -$10.4K
ANNX icon
213
Annexon
ANNX
$238M
$299K 0.12%
+11,958
New +$299K
SRRK icon
214
Scholar Rock
SRRK
$3.02B
$299K 0.12%
+6,154
New +$299K
IGMS
215
DELISTED
IGM Biosciences
IGMS
$298K 0.12%
3,374
-1,559
-32% -$138K
ZNTL icon
216
Zentalis Pharmaceuticals
ZNTL
$126M
$297K 0.12%
+5,711
New +$297K
DCF
217
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$297K 0.12%
35,039
+681
+2% +$5.77K
ALEC icon
218
Alector
ALEC
$305M
$296K 0.12%
19,563
+9,032
+86% +$137K
UROV
219
DELISTED
Urovant Sciences Ltd.
UROV
$296K 0.12%
+18,324
New +$296K
STRO icon
220
Sutro Biopharma
STRO
$89.9M
$295K 0.12%
+13,576
New +$295K
MORF
221
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$295K 0.12%
+8,778
New +$295K
CALA
222
DELISTED
Calithera Biosciences, Inc
CALA
$295K 0.12%
3,004
-12
-0.4% -$1.18K
BTAI icon
223
BioXcel Therapeutics
BTAI
$55.2M
$294K 0.12%
398
-7
-2% -$5.17K
MCI
224
Barings Corporate Investors
MCI
$434M
$294K 0.12%
22,320
-1,391
-6% -$18.3K
ISEE
225
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$294K 0.12%
+42,509
New +$294K